ClinicalTrials.Veeva

Menu

Fasted Exercise Training in Type 1 Diabetes (FED-T1D)

U

University of Alberta

Status

Enrolling

Conditions

Diabetes Mellitus, Type 1

Treatments

Behavioral: Postprandial Exercise
Behavioral: Fasted Exercise

Study type

Interventional

Funder types

Other

Identifiers

NCT06748963
RES0067483 (Other Identifier)
Pro00140125

Details and patient eligibility

About

This study compares aerobic exercise training performed before breakfast (i.e., in the fasted state) to similar training performed after breakfast in people with type 1 diabetes. Training will take place over 12 weeks.

Full description

People with type 1 diabetes (PwT1D) are encouraged to increase their physical activity (PA). Increasing the amount of PA can be difficult, especially for PwT1D who experience barriers to exercise. Therefore, simply recommending that PwT1D preform more exercise may not be the most effective prescription in the long term. Recent short-term studies have s suggest that exercise performed before eating (fasted) causes blood sugars to decrease less or even increase, compared exercise performed after a meal, which usually causes blood sugar to decrease. To date, no long-term study has compared the effects of exercise performed with or without eating beforehand in people with T1D.

This study will compare the effects of 12 weeks of exercise before breakfast compared to 12 weeks of exercise after breakfast. It is expected that exercise before breakfast (i.e., in the fasted state) will lead to larger reductions in overall insulin dose, without the addition of more exercise.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Clinical diagnosis of type 1 diabetes for 5 or more years.

  2. Treatment using an insulin pump with no change in treatment modality for > 2 continuous months and willing to share CGM data with the research team. Insulin delivery can be managed using either manual open-loop system (non-AID) or a hybrid closed loop (AID) systems.

  3. Using rapid (e.g., Aspart, Lispro or Glulisine) or ultra-rapid (e.g., FiAsp) acting insulin analogs.

  4. HbA1c 7.0-9.9%.

  5. Have BMI of 25 kg/m2 or above

  6. Have waist circumference associated with central obesity/metabolic syndrome as per Diabetes Canada definition

    • 94cm for males of European, Sub-Saharan African, Eastern Mediterranean and Middle Eastern descent
    • 90cm for males of South Asian, Chinese, Japanese, South and Central American descent
    • 80cm for females
  7. No history of stroke, myocardial infarction, or coronary artery disease

  8. Not wearing implantable device such as a pacemaker, neurostimulators, aneurysm clips, metal fragments, epicardial electrodes, cochlear implants, magnetic ocular implants, penile implants, magnetic tissue expander, some types of breast implants, magnetic orthopedic implants, magnetic dental implants, hearing Aids, intravascular implants, for example VCI filters, coils, stents, cardiac septum implants, ventricular bypass devices.

  9. Use a CGM in routine diabetes management.

Exclusion criteria

  1. Major complication within the previous 3 months (e.g., severe hypoglycemia requiring assistance, diabetic ketoacidosis, or cardiovascular event).
  2. Restriction in aerobic or resistance exercise due to significant diabetes complications (e.g., severe peripheral neuropathy, active proliferative retinopathy, etc.) or other type of limitations (e.g., orthopedic, severe arthritis, etc.).
  3. Uncontrolled hypertension (e.g., blood pressure >160 mmHg systolic or >100 mmHg diastolic).
  4. Implanted device, material, or having a condition contraindicated to MRI.
  5. Ongoing pregnancy or breastfeeding.
  6. Inability to give consent.
  7. Use of an injection-based insulin therapy (ex. multiple daily injections or combined pump and injection-based delivery).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

20 participants in 2 patient groups

Fasted Exercise
Experimental group
Description:
Exercise training will be performed in the fasted state (i.e., before breakfast).
Treatment:
Behavioral: Fasted Exercise
Postprandial Exercise
Active Comparator group
Description:
Exercise will be performed in the postprandial period (i.e., after breakfast)
Treatment:
Behavioral: Postprandial Exercise

Trial contacts and locations

1

Loading...

Central trial contact

Reid McClure, MSc; Normand Boule, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems